Addwize
Addwize contains Methylphenidate, a central nervous system stimulant. It is primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy by affecting chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
Dosage by Body Weight
Dosage should be individualized according to the needs and response of the patient. It is typically initiated at a low dose (e.g., 5 mg once or twice daily) and titrated weekly. Not recommended for children under 6 years of age.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy not established in this weight class or age group.
- Body Weight
- 5-7 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy not established in this weight class or age group.
- Body Weight
- 8-10 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy not established in children under 6 years of age.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Generally not recommended unless specifically prescribed by a specialist for children over 6 years.
- Body Weight
- 16-20 kg
- Dose
- 5 mg
- Frequency
- Once daily
- Tracking Notes
- Standard starting dose for children 6 years and older. Dosage must be titrated individually under specialist supervision.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated | Do not use | Safety and efficacy not established in this weight class or age group. |
| 5-7 kg | Contraindicated | Do not use | Safety and efficacy not established in this weight class or age group. |
| 8-10 kg | Contraindicated | Do not use | Safety and efficacy not established in children under 6 years of age. |
| 11-15 kg | Not routine | Use only if prescribed | Generally not recommended unless specifically prescribed by a specialist for children over 6 years. |
| 16-20 kg | 5 mg | Once daily | Standard starting dose for children 6 years and older. Dosage must be titrated individually under specialist supervision. |
Formulation
TabletExtended Release Tablet
Purpose
Treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Generic Name
MethylphenidateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.